As of 2024-12-13, the Relative Valuation of Cue Biopharma Inc (CUE) is (12.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.04 USD, the upside of Cue Biopharma Inc based on Relative Valuation is -1323.1%.
The range of the Relative Valuation is (12.21) - (13.46) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 24.4x | 17.5x |
| Forward P/E multiples | 12.5x - 19.1x | 18.8x |
| Fair Price | (12.21) - (13.46) | (12.78) |
| Upside | -1268.5% - -1388.5% | -1323.1% |
| Date | P/E |
| 2024-12-10 | -1.62 |
| 2024-12-09 | -1.62 |
| 2024-12-06 | -1.56 |
| 2024-12-05 | -1.49 |
| 2024-12-04 | -1.46 |
| 2024-12-03 | -1.62 |
| 2024-12-02 | -1.66 |
| 2024-11-29 | -1.73 |
| 2024-11-27 | -1.73 |
| 2024-11-26 | -1.55 |
| 2024-11-25 | -1.51 |
| 2024-11-22 | -1.45 |
| 2024-11-21 | -1.46 |
| 2024-11-20 | -1.55 |
| 2024-11-19 | -1.53 |
| 2024-11-18 | -1.56 |
| 2024-11-15 | -1.77 |
| 2024-11-14 | -2.13 |
| 2024-11-13 | -2.13 |
| 2024-11-12 | -2.41 |
| 2024-11-11 | -2.66 |
| 2024-11-08 | -2.44 |
| 2024-11-07 | -2.53 |
| 2024-11-06 | -2.34 |
| 2024-11-05 | -2.43 |
| 2024-11-04 | -2.12 |
| 2024-11-01 | -2.16 |
| 2024-10-31 | -2.29 |
| 2024-10-30 | -2.49 |
| 2024-10-29 | -2.40 |
| 2024-10-28 | -2.53 |
| 2024-10-25 | -2.10 |
| 2024-10-24 | -2.22 |
| 2024-10-23 | -2.23 |
| 2024-10-22 | -2.27 |
| 2024-10-21 | -2.39 |
| 2024-10-18 | -1.72 |
| 2024-10-17 | -1.58 |
| 2024-10-16 | -1.52 |
| 2024-10-15 | -1.59 |
| 2024-10-14 | -1.72 |
| 2024-10-11 | -1.75 |
| 2024-10-10 | -1.89 |
| 2024-10-09 | -1.71 |
| 2024-10-08 | -1.75 |
| 2024-10-07 | -1.97 |
| 2024-10-04 | -1.65 |
| 2024-10-03 | -1.16 |
| 2024-10-02 | -1.04 |
| 2024-10-01 | -1.02 |